Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 42951-43000 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05765786
Diagnosing Variable Primary Aldosteronism.
N/ARecruiting
100 participants
Started: Feb 24, 2023 · Completed: Feb 24, 2026
2 conditions1 sponsor1 location
NCT05471856
A Study to Test How Different Doses of BI 1703880 in Combination With Ezabenlimab Are Tolerated in People With Different Types of Advanced Cancer (Solid Tumours)
PHASE1Recruiting
66 participants
Started: Feb 24, 2023 · Completed: Sep 13, 2028
1 condition1 sponsor13 locations
NCT05663359
Study on Treatment of Varicose Veins by Endovenous Laser (1940 nm vs 1470 nm)
NARecruiting
280 participants
Started: Feb 24, 2023 · Completed: Feb 28, 2031
1 condition1 sponsor1 location
NCT05094089
Assessment of GORE® SYNECOR Biomaterial in Focused Patient Populations and Long-Term Application
N/ARecruiting
320 participants
Started: Feb 24, 2023 · Completed: Dec 31, 2028
3 conditions1 sponsor15 locations
NCT06292858
Safety/Tolerability, PK and Efficacy of IMB071703 Injection in Patients With Advanced Solid Tumors
PHASE1Recruiting
93 participants
Started: Feb 24, 2023 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT05302986
Effect on Post-operative Pain of Tranexamic Acid Injection During Shoulder Surgery
PHASE3Recruiting
220 participants
Started: Feb 24, 2023 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT05558605
Use of Artificial Intelligence-Guided Echocardiography to assIst cardiovascuLar Patient managEment
NARecruiting
612 participants
Started: Feb 24, 2023 · Completed: Jun 30, 2026
2 conditions9 sponsors1 location
NCT05410353
Choosing Healthy Activities and Lifestyle Management Through Portal Support
NARecruiting
250 participants
Started: Feb 24, 2023 · Completed: Dec 31, 2026
3 conditions2 sponsors1 location
NCT05642143
Deep Phenotyping of Bone Disease in Type 2 Diabetes and Relations to Diabetic Neuropathy
N/ARecruiting
300 participants
Started: Feb 24, 2023 · Completed: Apr 30, 2026
5 conditions1 sponsor1 location
NCT05746650
Improving Tissue Repair After Injury in the Muscle-tendon Interface Muscle Tissue Injury
NARecruiting
40 participants
Started: Feb 24, 2023 · Completed: Sep 1, 2027
1 condition1 sponsor1 location
NCT06369714
Neurofeedback-Based Digital Therapeutics for the Diagnosis and Treatment of ADHD in Children.
NARecruiting
210 participants
Started: Feb 24, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor2 locations
NCT05346848
Randomized Phase II Trial on Short Term Darolutamide Concomitant to Radiation Therapy for Patients With Intermediate Unfavorable Risk Prostate Cancer
PHASE2Recruiting
62 participants
Started: Feb 24, 2023 · Completed: Feb 28, 2030
1 condition2 sponsors10 locations
NCT05652790
Enhanced Rehabilitation After Major Trauma (PROPERLY)
NARecruiting
50 participants
Started: Feb 24, 2023 · Completed: Apr 30, 2025
1 condition2 sponsors1 location
NCT06286306
Pronostic Value of Fluid Responsiveness Evaluated by Inferior Vena Cava Collapsibility Index in Patients Admitted in ICU With Acute Respiratory Failure
N/ARecruiting
50 participants
Started: Feb 24, 2023 · Completed: May 25, 2025
1 condition1 sponsor1 location
NCT06118346
A Female-Specific CBT Group for Veteran Women With Alcohol Use Disorder in VA Primary Care Settings
NARecruiting
162 participants
Started: Feb 24, 2023 · Completed: Jan 30, 2026
2 conditions2 sponsors1 location
NCT05765084
Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural Mesothelioma
PHASE1/PHASE2Recruiting
15 participants
Started: Feb 24, 2023 · Completed: Oct 31, 2026
1 condition5 sponsors3 locations
NCT06133764
Different Modalities of Management of Odontogenic Keratocysts
NARecruiting
50 participants
Started: Feb 24, 2023 · Completed: Jan 31, 2026
1 condition2 sponsors1 location
NCT05598723
BOTOX® vs. XEOMIN® for Chronic Migraine
PHASE3Recruiting
128 participants
Started: Feb 24, 2023 · Completed: Aug 24, 2026
1 condition1 sponsor1 location
NCT05765006
CD19-CART(Relma-cel) for Moderate to Severe Active Systemic Lupus Erythematosus
PHASE1Recruiting
24 participants
Started: Feb 24, 2023 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT05781568
Use of Blood Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma (HCC)
N/ARecruiting
60 participants
Started: Feb 24, 2023 · Completed: Jan 27, 2025
5 conditions6 sponsors1 location
NCT05946083
The Brain, the Bug, and the Binge: the Interplay Between Binge Drinking, Gut Microbiota, and Brain Functioning
PHASE2Recruiting
82 participants
Started: Feb 24, 2023 · Completed: Nov 30, 2025
1 condition2 sponsors1 location
NCT06254560
Rituximab for Serious Aplastic Anemia With Platelet Transfusion Refractoriness
PHASE2Recruiting
20 participants
Started: Feb 23, 2023 · Completed: Dec 30, 2027
2 conditions1 sponsor1 location
NCT05065021
Using Genetic Profile to Determine the Treatment for Patients With Ovarian Cancer Who Previously Received a PARP-inhibitor
PHASE2Recruiting
40 participants
Started: Feb 23, 2023 · Completed: Jun 6, 2025
5 conditions2 sponsors1 location
NCT05218083
REmotely Monitored, Mobile Health Supported Multidomain Rehabilitation Program With High Intensity Interval Training for COVID-19
NARecruiting
120 participants
Started: Feb 23, 2023 · Completed: Nov 1, 2026
5 conditions7 sponsors5 locations
NCT05690581
Safety, Tolerability, Pharmacokinetic Characteristics, and Efficacy of CM369 in Advanced Solid Tumors & Hematologic Malignancies
PHASE1Recruiting
146 participants
Started: Feb 23, 2023 · Completed: Feb 28, 2026
1 condition1 sponsor3 locations
NCT05742776
The Relationship Between Ultrasonographic Findings and Sleep Quality in Carpal Tunnel Syndrome
N/ARecruiting
120 participants
Started: Feb 23, 2023 · Completed: Dec 1, 2025
5 conditions1 sponsor1 location
NCT05731518
SC0245 and Irinotecan in Treating Patients With Relapsed Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
PHASE1/PHASE2Recruiting
67 participants
Started: Feb 23, 2023 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT06131346
Clinical Characterization and Outcome of Anti-IgLON5 Disease
N/ARecruiting
50 participants
Started: Feb 23, 2023 · Completed: Dec 31, 2023
1 condition1 sponsor1 location
NCT05392894
RElated Haplo-DonoR Haematopoietic stEm Cell Transplantation for Adults With Severe Sickle Cell Disease
PHASE3Recruiting
120 participants
Started: Feb 23, 2023 · Completed: Mar 31, 2027
1 condition11 sponsors1 location
NCT05311605
REperfusion Therapy for Acute Ischemic STrOke Due to Large aRtEry Occlusion
N/ARecruiting
1,600 participants
Started: Feb 23, 2023 · Completed: Dec 31, 2024
5 conditions4 sponsors1 location
NCT05807789
Molecular-genetic Characterization in Patients Undergoing CAR-T Cell Infusion
N/ARecruiting
150 participants
Started: Feb 23, 2023 · Completed: May 31, 2027
1 condition1 sponsor1 location
NCT05194397
Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors
PHASE2Recruiting
80 participants
Started: Feb 23, 2023 · Completed: Jun 30, 2026
5 conditions6 sponsors3 locations
NCT05727787
vGRID SBRT: A Phase I Clinical Trial in Unresectable or Metastatic HCC
NARecruiting
18 participants
Started: Feb 23, 2023 · Completed: Dec 28, 2025
1 condition2 sponsors1 location
NCT05608252
VS-6766+Abema+Fulv in Met HR+/HER- BC
PHASE1/PHASE2Recruiting
63 participants
Started: Feb 23, 2023 · Completed: Dec 31, 2028
3 conditions3 sponsors3 locations
NCT05648240
Proof-of-concept Study of Blood Markers of Tumor Dissemination in Patients with Versus Without Intestinal Polyps
N/ARecruiting
120 participants
Started: Feb 23, 2023 · Completed: Feb 28, 2026
3 conditions1 sponsor1 location
NCT05523869
Intravitreal Topotecan in the Repair of Rhegmatogenous Retinal Detachment with Proliferative Vitreoretinopathy
PHASE2Recruiting
50 participants
Started: Feb 23, 2023 · Completed: Feb 28, 2026
1 condition1 sponsor2 locations
NCT05676450
Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Disease for Lymphoma Patients Across Community Centers in Texas
NARecruiting
517 participants
Started: Feb 23, 2023 · Completed: Aug 31, 2026
1 condition1 sponsor2 locations
NCT06238882
Nitroglycerin Plus Radiotherapy Versus Conventional Radiotherapy in Patients With Lung Cancer.
NARecruiting
74 participants
Started: Feb 23, 2023 · Completed: Feb 15, 2026
3 conditions1 sponsor1 location
NCT05718856
TPO-RAs Combining Anti-CD 20 Monoclonal Antibody Versus TPO-RAs in the Management of Pediatric Primary Immune Thrombocytopenia (ITP)
PHASE4Recruiting
166 participants
Started: Feb 23, 2023 · Completed: Nov 14, 2025
1 condition7 sponsors1 location
NCT05656469
Clinical Study Evaluating Pharmacogenomics-informed Pharmacotherapy Versus Dosing as Usual in Psychiatric Disorders
NARecruiting
2,500 participants
Started: Feb 23, 2023 · Completed: Sep 30, 2026
3 conditions9 sponsors9 locations
NCT05469360
Study of Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of NIO752 in Early Alzheimer's Disease Participants
PHASE1Recruiting
36 participants
Started: Feb 23, 2023 · Completed: Jan 2, 2028
2 conditions1 sponsor10 locations
NCT05101551
Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy
PHASE1Recruiting
34 participants
Started: Feb 23, 2023 · Completed: Mar 31, 2026
1 condition2 sponsors9 locations
NCT05606146
IUB SEAD RED (Revolutionary Endometrial Ablation Device Study)
NARecruiting
10 participants
Started: Feb 23, 2023 · Completed: Jul 31, 2024
1 condition1 sponsor1 location
NCT06312969
Technological Gaming in Cancer Survivors (WINNERS)
NARecruiting
56 participants
Started: Feb 23, 2023 · Completed: Feb 28, 2025
1 condition3 sponsors1 location
NCT05027945
A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome
PHASE2Recruiting
54 participants
Started: Feb 23, 2023 · Completed: Jul 1, 2026
2 conditions1 sponsor1 location
NCT06419049
Impact of Standing Programs in Children With Spina Bifida: A Single Subject Design
NARecruiting
12 participants
Started: Feb 23, 2023 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT05699811
IFNα Expressing Mesenchymal Stromal Cells for Locally Advanced/Metastatic Solid Tumors
PHASE1/PHASE2Recruiting
40 participants
Started: Feb 23, 2023 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT05394337
Neoadjuvant PD-1 Plus TIGIT Blockade in Patients With Cisplatin-Ineligible Operable High-Risk Urothelial Carcinoma
PHASE1/PHASE2Recruiting
10 participants
Started: Feb 23, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04663399
IMMunological ResPonse Assessment AfteR Acute ISchemic Stroke Treated with Endovascular Therapy (IMPRESS)
N/ARecruiting
400 participants
Started: Feb 23, 2023 · Completed: May 23, 2028
2 conditions1 sponsor1 location
NCT05704647
Phase II Study of Nivolumab in Combination With Relatlimab in Patients With Active Melanoma Brain Metastases
PHASE2Recruiting
30 participants
Started: Feb 23, 2023 · Completed: Jul 31, 2028
1 condition1 sponsor1 location